Hilary Wilson

Hilary Wilson is an experienced professional in the fields of medicine and regulatory affairs, currently serving as Director of US Medicine & Regulatory Affairs Strategy and Operations and Director of Patient Engagement at Boehringer Ingelheim since September 2018. Previously, Hilary held various roles at Evidera from June 2012, including Director of Patient Engagement and Research Scientist, focusing on the design and implementation of patient-reported outcome studies. Hilary's academic tenure as Assistant Professor at the University of Washington from June 2009 involved health outcomes research in Pain Medicine, employing qualitative and quantitative methodologies to enhance patient outcomes. Additionally, as Associate Director of Research at the Center for Pain Research on Impact, Measurement, and Effectiveness, Hilary advanced research in pain management and treatment response prediction. Hilary holds an MS and PhD in Experimental Psychology from The University of Texas at Arlington and a BA in Psychology from Cornell College.